Gut Healing Research Stack
Reviewed by the BestHealingPeptides Editorial Team ·
Examine complementary effects on mucosal repair, inflammatory cytokine release, and tight-junction integrity in pre-clinical gut models.
Components
BPC-157
tendon-ligament · gut-healing · anti-inflammatory · regeneration
KPV
gut-healing · anti-inflammatory
Larazotide
gut-healing
Protocol notes
Oral delivery is a recurring practical challenge. BPC-157 has reported activity after oral gavage in rodents; KPV is typically encapsulated for colonic delivery; larazotide is designed for luminal action with minimal systemic absorption.
Mechanistic rationale
BPC-157 acts on mucosal angiogenesis and gastric protection through VEGFR2-Akt-eNOS-driven capillary regeneration and NO-system stabilisation at the ulcer base. It maintains tight-junction protein expression (claudin-4, occludin) in NSAID-enteropathy and DSS-colitis models and reduces bacterial translocation across the compromised barrier. KPV suppresses NF-κB-driven pro-inflammatory cytokine transcription (TNF-α, IL-1β, IL-6) in mucosal epithelial cells and macrophages after PepT1-mediated cellular entry — a mechanism specifically active in inflamed mucosa where PepT1 is upregulated. Larazotide modulates intestinal tight junctions at the luminal surface through zonulin-receptor antagonism, preventing zonulin-driven ZO-1 redistribution and consequent paracellular flux. The three components address complementary aspects of gut healing — mucosal regeneration, inflammatory-cytokine suppression, and barrier integrity respectively — with mechanistically distinct rather than redundant pharmacology.
Endpoint suggestions
Macroscopic disease activity index (DAI) captures weight loss, stool consistency, and bleeding in murine colitis. Histological scoring uses Wallace, Geboes, or modified Baron criteria on H&E-stained colonic sections. Colon length shortening is a reproducible acute-injury marker. Faecal calprotectin (or its rodent lipocalin-2 equivalent) tracks neutrophilic inflammation non-invasively. Intestinal permeability is assessed by lactulose/mannitol urinary ratio in vivo or FITC-dextran (4 kDa) paracellular flux ex vivo. Tissue cytokine ELISA panels (TNF-α, IL-1β, IL-6, IL-10, IFN-γ) provide mechanistic readouts. Tight-junction protein localisation (ZO-1, occludin, claudin-4) by immunofluorescence adds structural confirmation of barrier response.
Confounders
Stress, microbiome composition, and vehicle pH can dominate signal in gut models. Strict standardisation of housing (individually ventilated cages vs open racks), bedding, diet composition, and water source is essential — supplier-of-origin microbiome differences can produce distinct baseline colonic phenotypes. Animals should be co-housed or littermate-controlled to minimise inter-cage microbiome drift. The colitis-induction model (DSS dose and duration, TNBS protocol, IL-10 knockout, T-cell transfer) materially affects which mechanistic readouts are most informative and should be pre-registered. Vehicle pH is critical — larazotide operates at the luminal surface where gastric acid may inactivate it if not adequately protected, and KPV nanoparticle encapsulation is pH-sensitive.
Where to source research peptides for laboratory research
The following UK-based suppliers stock research-grade, lyophilised peptides for in-vitro and pre-clinical work. Purity and provenance vary; always request a Certificate of Analysis (CoA) and confirm cold-chain storage on arrival. None of the products linked below are approved for human use.
- PeptideAuthority.co.uk
UK-based research peptide supplier with batch certificates of analysis and >99% purity testing.
- PeptideBarn.co.uk
Wide catalogue of research-grade lyophilised peptides shipped from the UK, including bulk vials.